Overview
- SupplierMabtech
- Product NameELISpot Plus: Human IFN-gamma (HRP)
- Delivery Days Customer9
- ApplicationsELISpot Assay
- Assay SpecificityThis kit is based on a matched pair of mAbs specific for human IFN-gamma.
- CertificationResearch Use Only
- ReactivityHuman
- UNSPSC41116133
References
- Lunemann, J. D., et al. (2008). EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. The Journal of experimental medicine.Read more
- Ott, P. A., et al. (2017). An immunogenic personal neoantigen vaccine for patients with melanoma. Nature.Read more
- Kranz, L. M., et al. (2016). Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature.Read more
- Sahin, U., et al. (2017). Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature.Read more
- Czerkinsky, C., et al. (1988). Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. Journal of immunological methods.Read more